Latest News

None
News

Economic development honor among ORNL’s 5 federal laboratory awards

Economic development honor among ORNL’s 5 federal laboratory awards

dunlapkk@ornl.gov Mon, 02/14/2022 - 07:52

ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.

None
News

Esteemed batteries researcher Dudney named to National Academy of Engineering

Esteemed batteries researcher Dudney named to National Academy of Engineering

shoemakerms@ornl.gov Thu, 02/10/2022 - 09:00

Materials scientist and chemist Nancy Dudney has been elected to the National Academy of Engineering for her groundbreaking research and development of high-performance solid-state rechargeable batteries.

<p>Members of the Wyss Institute and Alkem Laboratories at the signing of the licensing agreement, from left to right: Jay Nadkarni (Alkem), Paul Resnick (Wyss Institute), Akhilesh Sharma (Alkem), Don Ingber (Wyss Institute), Sandeep Singh (Alkem). Credit: Wyss Institute at Harvard University</p>
News

Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases

By Lindsay Brownell (BOSTON) – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD),…

<p>Members of the Wyss Institute and Alkem Laboratories at the signing of the licensing agreement, from left to right: Jay Nadkarni (Alkem), Paul Resnick (Wyss Institute), Akhilesh Sharma (Alkem), Don Ingber (Wyss Institute), Sandeep Singh (Alkem). Credit: Wyss Institute at Harvard University</p>
News

Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases

By Lindsay Brownell (BOSTON) – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD),…

None
News

ORNL’s Piyush Sao receives supercomputing paper prize

ORNL’s Piyush Sao receives supercomputing paper prize

rosenthalec@ornl.gov Wed, 02/09/2022 - 10:03

Piyush Sao, a research scientist in Oak Ridge National Laboratory’s Computing and Computational Sciences Directorate, has received the Best Paper Prize from the Society for Industrial and Applied Mathematics (SIAM) Activity Group on Supercomputing.

None
News

ORNL’s Olivera Kotevska recognized by IEEE

ORNL’s Olivera Kotevska recognized by IEEE

rosenthalec@ornl.gov Wed, 02/09/2022 - 09:51

Olivera Kotevska, a research scientist in Oak Ridge National Laboratory’s Computing and Computational Sciences Directorate, has been awarded senior membership by the Institute of Electrical and Electronics Engineers, the world’s largest association for technical professionals.

ORNL fusion scientist Elijah Martin is working with TAE Technologies to demonstrate the feasibility of field-reversed configuration reactors, a possible alternative to the traditional tokamak-based devices. Credit: ORNL.
News

INFUSE supports public-private collaboration to solve challenges for fusion energy

INFUSE supports public-private collaboration to solve challenges for fusion energy

pearcejw@ornl.gov Tue, 02/08/2022 - 07:51

ORNL manages the Innovation Network for Fusion Energy Program, or INFUSE, with Princeton Plasma Physics Laboratory, to help the private sector find solutions to technical challenges that need to be resolved to make practical fusion energy a reality.